John F Palma
Inventor
Stats
- 7 US patents issued
- 22 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 7 US Patents Issued
- 22 US Applications Filed
- 259 Total Citation Count
- Dec 28, 2022 Most Recent Filing
- Dec 2, 2002 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
UNIVERSITY OF MASSACHUSETTS | 2
1 | 2006
2009 |
MENARINI SILICON BIOSYSTEMS, INC. | 1
| 2015
|
PHILIP S. JOHNSON;JOHNSON & JOHNSON | 1
| 2012
|
METABOLEX, INC. | 1
1 1 | 2004
2007 2008 |
VERIDEX, LLC | 1
1 1 1 | 2008
2010 2012 2013 |
CYMABAY THERAPEUTICS, INC. | 2
4 4 | 2002
2003 2006 |
JANSSEN PHARMACEUTICA NV | 2
| 2013
|
ORTHO-CLINICAL DIAGNOSTICS, INC. | 1
| 2010
|
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 1
1 | 2003
2004 |
AFFYMETRIX, INC. | 1
1 2 | 2003
2004 2005 |
Inventor Addresses
Address | Duration |
---|---|
Alamo, CA, US | May 23, 13 - Aug 27, 24 |
Carlsbad, CA, US | Jan 13, 11 - Aug 22, 13 |
Carsbad, CA, US | May 19, 16 - May 19, 16 |
Dedham, MA | Oct 18, 07 - Oct 18, 07 |
Dedham, MA, US | Dec 08, 09 - May 06, 10 |
San Ramon, CA | Feb 12, 04 - Dec 25, 08 |
San Ramon, CA, US | Oct 30, 03 - Feb 17, 09 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 4 |
C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 4 |
C07K: | PEPTIDES | 6 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
12071661 | 2024 | Method of predicting response to therapy by assessing tumor genetic heterogeneity | 0 |
2023/0270,769 | 2023 | Method of Determining Acute Myeloid Leukemia Response to Treatment With Farnesyltransferase Inhibitors | 0 |
11559540 | 2023 | Method of determining acute myeloid leukemia response to treatment with farnesyltransferase inhibitors | 0 |
2021/0002,719 | 2021 | METHOD OF PREDICTING RESPONSE TO THERAPY BY ASSESSING TUMOR GENETIC HETEROGENEITY | 0 |
2016/0138,103 | 2016 | DIAGNOSTIC BIOMARKERS OF DIABETES | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.